Title |
Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critical ill patients?
|
---|---|
Published in |
Annals of Intensive Care, December 2017
|
DOI | 10.1186/s13613-017-0337-7 |
Pubmed ID | |
Authors |
Antoine Dewitte, Sébastien Lepreux, Julien Villeneuve, Claire Rigothier, Christian Combe, Alexandre Ouattara, Jean Ripoche |
Abstract |
Beyond haemostasis, platelets have emerged as versatile effectors of the immune response. The contribution of platelets in inflammation, tissue integrity and defence against infections has considerably widened the spectrum of their role in health and disease. Here, we propose a narrative review that first describes these new platelet attributes. We then examine their relevance to microcirculatory alterations in multi-organ dysfunction, a major sepsis complication. Rapid progresses that are made on the knowledge of novel platelet functions should improve the understanding of thrombocytopenia, a common condition and a predictor of adverse outcome in sepsis, and may provide potential avenues for management and therapy. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 25% |
United Kingdom | 1 | 25% |
Denmark | 1 | 25% |
Unknown | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 239 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 28 | 12% |
Student > Master | 25 | 10% |
Student > Postgraduate | 22 | 9% |
Other | 20 | 8% |
Researcher | 20 | 8% |
Other | 48 | 20% |
Unknown | 76 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 88 | 37% |
Biochemistry, Genetics and Molecular Biology | 21 | 9% |
Agricultural and Biological Sciences | 10 | 4% |
Immunology and Microbiology | 10 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 3% |
Other | 19 | 8% |
Unknown | 83 | 35% |